Topic: Coronavirus

Latest content

Why Germany is opposing the WTO’s decision to suspend patent protection

While WTO member states have expressed general sympathy for the goal to provide broad access to vaccine technology during the pandemic, Germany continues to favour patent protection over compulsory licensing.

16 November 2022

Eight steps for protecting trade secrets in the world of remote work

Featured in Special Report 2022 Q4: Trade secret strategy playbook

16 November 2022

Why compulsory licensing is a blunt instrument in the post-covid landscape

Turkey’s recent compulsory licence decision shines a light on the questionable use of compulsory licence provisions around the world in relation to the pandemic. The creation of the covid vaccine has sparked discussions on IP rights and where the real regulatory focus should be.

28 September 2022

How the pandemic has hit patent procurement

Featured in Special Report 2022 Q3: Patent Portfolio Management

Dr Michael A Sartori and Sarah Hassan of Baker Botts explore the impact that covid-19 has had on new application filings and application abandonments, revealing some interesting contrasts with previous financial disruptions

13 September 2022

Intentional connection, innovation incentives key to growing monetisable patent portfolio

Dolby Laboratories’ director of IP strategy and operations provides best practices for building valuable patent and trademark portfolios against a backdrop of global crises

08 September 2022

Pfizer/BioNTech strike back in covid vaccine patent war with first UK action

Companies seek non-infringement and invalidity judgment against CureVac, which launched a suit against them in Germany in July

06 September 2022

Covid court backlog triggered US ITC workload uptick, data suggests

Disputes increased the most in technology centres covering computers, semiconductors and networking while patent owners won favourable determinations in many cases

22 August 2022

There are dangers in excluding the unvaccinated from jury service in US patent cases

Courts striking-out those who have not had covid-19 jabs may unintentionally be eliminating people from diverse demographics holding multiple world views

16 July 2022

Covid-19 patent wars spread to Europe as CureVac sues BioNTech

German mRNA innovators poised for fight over vaccine revenues in the Dusseldorf Regional Court

08 July 2022

Covid-19 has exposed the limits of compulsory licensing

The pandemic has brought the difficulties of bypassing life sciences IP into plain view

02 July 2022

Unlock unlimited access to all IAM content